| Joan S Schlenk, ARNP | |
|
3500 Dalton Way Sw Ste 400, Cedar Rapids, IA 52404-2567 | |
| (319) 369-4340 | |
| (319) 369-4341 |
| Full Name | Joan S Schlenk |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 3500 Dalton Way Sw Ste 400, Cedar Rapids, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053427591 | NPI | - | NPPES |
| 0476903 | Medicaid | IA | |
| 06210 | Other | IA | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | H062973 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joan S Schlenk, ARNP 3500 Dalton Way Sw Ste 400, Cedar Rapids, IA 52404-2567 Ph: (319) 369-4340 | Joan S Schlenk, ARNP 3500 Dalton Way Sw Ste 400, Cedar Rapids, IA 52404-2567 Ph: (319) 369-4340 |
News Archive
In a briefing today at the Kaiser Family Foundation on "Opportunities for Long-Term Services and Supports in the Health Reform Law," U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius reinforced the Administration's commitment to moving forward with the implementation of Community Living Assistance Services and Supports (CLASS) Act.
As the difficulty of making a decision based on sensory evidence increases, activity in the brain's insular cortex also increases, according to researchers at Georgia State University.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).
With funding from the Biotechnology and Biological Sciences Research Council (BBSRC) neurobiologists from the Institute of Psychiatry and tissue engineers from The University of Nottingham have joined forces to tackle the challenge of tissue loss as a result of stroke.
› Verified 8 days ago
Erin Burns, MSN, ARNP, NNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 701 10th St Se, Cedar Rapids, IA 52403 Phone: 319-398-6011 | |
Dr. Jennifer Lee Wittman, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 275 10th St Se, Cedar Rapids, IA 52403 Phone: 319-247-3010 | |
Jerica Samson, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 202 10th St Se, Cedar Rapids, IA 52403 Phone: 319-399-2022 | |
Jennifer Bradley, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 701 10th St Se, Cedar Rapids, IA 52403 Phone: 319-369-4777 Fax: 319-369-4694 | |
Brooke Shivers, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 830 1st Ave Ne, Cedar Rapids, IA 52402 Phone: 319-369-8153 | |
Nicole M Pruchno, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 202 10th St Se, Cedar Rapids, IA 52403 Phone: 319-297-2900 | |
Melinda Sue White, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 411 10th St Se Ste 150, Cedar Rapids, IA 52403 Phone: 800-777-8442 |